Arima Genomics Completes Series A Financing

SAN DIEGO–(BUSINESS WIRE)–Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, announces that it has completed its Series A round of financing. Agilent Technologies, Inc. (NYSE: A) and Cowin Venture led this round, joined by Vectr Ventures and Berkeley Catalyst Fund. “Agilent invests in industry partners to advance the development of new technologies that will accelerate the pa

Click to view original post